Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Multiple Myeloma
Multiple Myeloma
Weekend ASH presentations hint at future of BCMA CARs
BioCentury
Tue, 12/4/18 - 09:39 am
ASH 2018
BCMA
CAR-T
Multiple Myeloma
ASH18: Legend's CAR-T brought back to reality
Biopharma Dive
Mon, 12/3/18 - 10:53 pm
Legend Biotech
ASH 2018
CAR-T
Multiple Myeloma
ASH: Takeda maintenance data sets up Ninlaro for new myeloma nod
Fierce Pharma
Sun, 12/2/18 - 12:34 pm
ASH2018
Takeda
Ninlaro
Multiple Myeloma
Bristol-Myers Squibb snags quick Empliciti combo nod in multiple myeloma
Fierce Pharma
Thu, 11/8/18 - 09:41 am
Bristol-Myers Squibb
AbbVie
Empliciti
FDA
Multiple Myeloma
Celgene
Pomalyst
FDA Clears Two IND Applications for Fortis Therapeutics Novel Anti-CD46 Candidate for Prostate Cancer and Multiple Myeloma
CP Wire
Tue, 11/6/18 - 09:31 am
Fortis Therapeutics
prostate cancer
Multiple Myeloma
FDA Clears Two IND Applications for Fortis Therapeutics Novel Anti-CD46 Candidate for Prostate Cancer and Multiple Myeloma
Tue, 11/6/18 - 09:23 am
Fortis Therapeutics
prostate cancer
Multiple Myeloma
Genmab and Johnson & Johnson’s Darzalex Dazzles in Multiple Myeloma Trial
BioSpace
Tue, 10/30/18 - 12:06 pm
JNJ
Janssen
Genmab
Darzalex
clinical trials
Multiple Myeloma
Takeda blesses a little biotech’s engineered toxin tech for multiple myeloma, triggering a bases loaded home run
Endpoints
Wed, 09/19/18 - 11:20 pm
Molecular Templates
Takeda
Multiple Myeloma
Johnson & Johnson Seeks EU and US Label Expansion for Darzalex
Market Realist
Thu, 09/13/18 - 11:34 am
JNJ
Janssen
Darzalex
daratumumab
Europe
Multiple Myeloma
Can Amgen's new-and-improved Kyprolis kick-start myeloma sales?
Fierce Pharma
Fri, 08/31/18 - 11:53 pm
Amgen
Kyprolis
Multiple Myeloma
Bristol-Myers (BMY) sBLA for Empliciti Gets Priority Review
Yahoo/Zacks.com
Fri, 08/24/18 - 11:08 am
Bristol-Myers Squibb
Empliciti
Celgene
Pomalyst
Multiple Myeloma
Can Celgene’s Most Important Drugs Keep Growing?
Motley Fool
Sun, 07/29/18 - 11:01 am
Celgene
Multiple Myeloma
Celgene tweaks trial of myeloma CAR-T bb2121, raising dose
Fierce Biotech
Fri, 07/13/18 - 09:44 am
Celgene
clinical trials
bb2121
Bluebird Bio
Multiple Myeloma
CAR-T
Takeda's Ninlaro Met Primary Endpoint in Ph III Trial In Patients with Multiple Myeloma Post Stem Cell Transplant
CP Wire
Wed, 07/11/18 - 10:15 am
Takeda
Ninlaro
Multiple Myeloma
Takeda's Ninlaro Met Primary Endpoint in Ph III Trial In Patients with Multiple Myeloma Post Stem Cell Transplant
Wed, 07/11/18 - 09:56 am
Ninlaro
Takeda Pharmaceuticals
Multiple Myeloma
Bristol-Myers, AbbVie eye new use for myeloma drug Empliciti after phase 2 combo win
Fierce Pharma
Mon, 06/18/18 - 09:47 pm
Bristol-Myers Squibb
AbbVie
Empliciti
Multiple Myeloma
Bluebird Bio's "Impressive" Killer T-Cells Battle Myeloma, But Are Not A Cure Yet
Forbes
Fri, 06/1/18 - 10:48 pm
Bluebird Bio
CAR-T
Multiple Myeloma
bb2121
ASCO 2018
J&J hustles Legend’s promising BCMA CAR-T into PhI/II trial, winning an FDA green light to begin recruiting patients
Endpoints
Wed, 05/30/18 - 08:34 pm
Legend Biotech
CAR-T
LCAR-B38M
Multiple Myeloma
Janssen obtains FDA approval for Darzalex (multiple myeloma)
GoinPharma
Sun, 05/13/18 - 03:52 pm
Janssen
JNJ
Darzalex
Takeda
Velcade
Multiple Myeloma
FDA
Karyopharm to pursue FDA approval for multiple myeloma drug based on new study results
Stat
Mon, 04/30/18 - 07:33 pm
Karyopharm Therapeutics
FDA
Multiple Myeloma
Selinexor
clinical trials
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »